Longevity UnmaskedLongevity Unmasked

Question 415 of 433

Are cancer vaccines real?

Vials in a bright futuristic lab

The short answer

Yes. Personalized vaccines built from a patient’s own tumor have now succeeded in a Phase 3 trial in melanoma.

These use the same mRNA technology as the COVID vaccines. A sample of the tumor is sequenced, and a vaccine is made that teaches the immune system to recognize that one patient’s cancer. In people with high-risk melanoma that had been surgically removed, adding the vaccine to standard immune therapy cut the risk of recurrence or death by about half over five years in a mid-stage trial. In August 2026 the companies announced that the larger confirming trial had met its goals. Trials are under way in lung, kidney, bladder, and pancreatic cancer.

These treat people who already have cancer. Vaccines that prevent cancer in healthy people, beyond HPV and hepatitis B, are much further off.

“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer

Evidence scope
HUMAN TRIALS / SPONSOR TOPLINE — Resected high-risk melanoma: individualized vaccine plus immunotherapy; not general cancer prevention.Evidence grade (draft mapping)Grade pendingPart 28, Q415 · Sources: R16

Sources cited

  • R16 Merck and Moderna. Phase 3 INTerpath-001 trial of intismeran autogene plus pembrolizumab met recurrence-free and distant metastasis-free survival endpoints. August 19, 2026. Link pending verification
All of Part 28

Related questions